$PRPO·4

TRANSGENOMIC INC · Sep 17, 5:13 PM ET

TRANSGENOMIC INC 4

4 · TRANSGENOMIC INC · Filed Sep 17, 2012

Insider Transaction Report

Form 4
Period: 2012-09-12
COLONNESE MARK P
Chief Financial Officer
Transactions
  • Award

    Purchase Option

    2012-09-12+83,33383,333 total
    Exercise: $0.98From: 2014-10-01Exp: 2022-09-11Common Stock (83,333 underlying)
  • Award

    Purchase Option

    2012-09-12+83,33483,334 total
    Exercise: $0.98From: 2013-10-01Exp: 2022-09-11Common Stock (83,334 underlying)
  • Award

    Purchase Option

    2012-09-12+83,33383,333 total
    Exercise: $0.98From: 2015-10-01Exp: 2022-09-11Common Stock (83,333 underlying)
Footnotes (2)
  • [F1]Common Stock, par value $.01 per share of Transgenomic, Inc.
  • [F2]The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitles the reporting person to purchase up to an aggregate of 250,000 shares of Common Stock, par value $.01 per share of Transgenomic, Inc.

Documents

1 file
  • 4
    v323949_form4.xmlPrimary

    FORM 4